C. Pothoulakis
Inflammatory Bowel Disease Center, Division of Digestive Diseases, UCLA, Los Angeles, California
ORCID: 0000-0002-5311-2634- Papers in database
- 6
- Primary author
- 1 paper
- Years active
- 1993 – 2012
Papers (6)
- 2012Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders10.1177/1756283X11428502
- 2009Saccharomyces boulardii inhibits EGF receptor signaling and intestinal tumor growth in Apc(min) mice.10.1053/j.gastro.2009.05.050
- 2006Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression.10.1016/J.BBRC.2006.02.080
- 2001Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice10.1128/IAI.69.4.2762-2765.2001
- 1999Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa10.1128/IAI.67.1.302-307.1999
- 1993Primary authorSaccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.10.1016/0016-5085(93)90280-P